Approval · Notice of Compliance 33930 · 2024
ADHEROZA: Notice of Compliance 33930
Issued August 20, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33930
- Date
- August 20, 2024
- Company
- Accord Healthcare IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- HERCEPTIN
Products in this notice
Medicinal ingredients
- TRASTUZUMAB 150 MG per VIAL
- TRASTUZUMAB 420 MG per VIAL